USPTO 2015–2025 USPTO PatentsView US Corporation

Singular Genomics Systems, Inc.

USPTO PatentsView assignee record - 115 granted patents across 26 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

RSS updates for this company

The verdict

According to USPTO PatentsView, Singular ranks #3,267 of 49,997 tracked US assignees by granted-patent volume, with 115 patents across 26 technology areas.

#3,267
of 49,997 US assignees by volume
Top 1%
by Innovation Score (66.2/100)
19.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R3267 · US Corporation #3,267 · 115 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MID 115 grants
  • TOP-DECILE #3,267/49,997
  • PHOTO-FINISH Omron Automotive
  • CPC-FOCUS C12Q · 26 areas
  • INNOV-STRONG 66.2/100
  • CLAIMS-RICH 19.6 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2020–2025 · 6y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Omron Automotive Electronics Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Singular

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Singular's Innovation Score is 66.2/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Singular's grants concentrate

Singular Genomics Systems, Inc. is a focused PatentsView assignee: 26 CPC subclasses with 65.2% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2024 (41 grants) versus a trough of 2 in 2020. By volume, Singular sits between Omron Automotive Electronics Co., Ltd. and Asana, Inc..

Singular's three-year grant acceleration

Singular Genomics Systems, Inc. shows 81 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Singular's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Singular holds 115 patents at rank #3,267, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Singular

By rank, the assignees closest to #3,267 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Singular's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Singular, neither rank-band nor same-CPC leaders (those blocks stay above).

Singular's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

66 Top 1% higher than 99% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

01020304050 202020212022202320242025 27
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Singular Genomics Systems, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 2 1.7%
2021 5 4.3%
2022 15 13.0%
2023 25 21.7%
2024 41 35.7%
2025partial year 27 23.5%

Which technologies does Singular Genomics Systems, Inc. patent most?

Top 15 of 26 technology areas

Where it ranks

Overall rank by patents

#3,267

of 49,997 tracked assignees

Innovation Score

66.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Singular Genomics Systems, Inc.'s patent record in context - here's where to go next.

  • Singular Genomics Systems, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 65.2% of its portfolio - see every assignee active in that class. Explore C12Q
  • Ranked #3,267 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Singular Genomics Systems, Inc. against Omron Automotive Electronics Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 66.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.